This course systematically outlines the full scope of cross-border intellectual property practice between Japan and South Korea, centered on the Korean Patent Act (KPA). It covers KIPO (Korean Intellectual Property Office) procedures, government fees, PCT national phase entry, the three-tiered court system comprising the Intellectual Property Trial and Appeal Board (IPTAB), the Intellectual Property Court, and the Supreme Court, as well as patent term extension (PTE), specifically tailored for practitioners handling patent applications, grant, and enforcement in South Korea.A patent attorney will explain the practical key points for this key market, where Japanese companies file the most applications in Asia.
Key Points of This Article
KOREA PATENT
A comprehensive guide to the Korean patent system and practice by a patent attorney well-versed in both Japanese and Korean practices. It systematically explains the process from application to KIPO examination, IPTAB trials, and Patent Court litigation across 12 sections.
Korean patent practice follows a "Japanese-style statutory law" structure, centered on the Korean Patent Act (KPA), with the Enforcement Decree and Enforcement Rules of the Korean Patent Act, KIPO Examination Guidelines, case law (Supreme Court and Patent Court), and the KIPO Practice Manual collectively governing scope of rights, examination, and disputes in a multi-layered manner.
Four Key Points to Keep in Mind in Korean Patent Practice
The “primary law” of the Korean patent system is the Patent Act (특허법), with Article 29 (Novelty and Inventive Step), Article 42 (Requirements for Description in the Specification), Article 97 (Scope of Rights), and Article 126 (Right to Seek an Injunction Against Infringement) forming its core.Procedural operations are specified in the Enforcement Decree of the Patent Act (특허법 시행령) and the Enforcement Rules of the Patent Act (특허법 시행규칙), while examination standards are detailed in the KIPO Patent and Utility Model Examination Guidelines.
KIPO, under the Ministry of Trade, Industry and Energy (산업통상자원부), is designated as the responsible entity for administrative functions such as patent grant, utility model registration, design registration, and trademark registration. In practice, it establishes the “effective rules” for the operation of the system through the following three functions:
| Forum | Jurisdiction and Characteristics | Legal Basis |
|---|---|---|
| Patent Trial and Appeal Board (IPTAB) | First-instance court for invalidation trials, revocation trials, and appeals against rejection decisions. A quasi-judicial body within KIPO | Patent Act §132-3 |
| Patent Court (특허법원) | Exclusive jurisdiction over lawsuits to overturn IPTAB decisions + appellate jurisdiction for certain infringement cases. A specialized judicial court located in Daejeon | Court Organization Act |
| Supreme Court (대법원) | Appeals against judgments of the Patent Court. The Supreme Court of Korea | Court Organization Act |
| District Courts (Seoul Central District Court, etc.) | First-instance trials for patent infringement lawsuits. The Seoul Central District Court serves as the de facto central court | Civil Procedure Act |
| Item | Direct Filing | Paris Convention Priority (Based on Japan) | Transition to Korea via PCT |
|---|---|---|---|
| Legal Status | First Filing in Korea | Inherits the priority date of the Japanese application | Patent Act §201 (PCT National Phase Entry) |
| Deadline for Filing in Korea | Anytime | Within 12 months from the Japanese filing date | Within 31 months from the priority date |
| Translation Requirements | Korean specification required | Korean specification required | Submit Korean translation at the time of transfer |
| Deadline for Requesting Examination | Within 3 years from the filing date | Within 3 years from the Korean filing date | Within 3 years from the international filing date |
| Benefits for Japanese Companies | Simplicity of a standalone application | Linkage with the Japanese basic application and cost efficiency | Effective for multi-country filings; 31-month grace period |
Standard processing time: Approximately 12–16 months from the request for examination to the issuance of the first Office Action; typically 2–3 years until registration. This can be shortened to 6–12 months by utilizing the Priority Processing Program (PPH).
| Item | Electronic Filing | Paper Filing | Conversion to Japanese Yen (for reference) |
|---|---|---|---|
| Application Fee (Basic) | KRW 46,000 | KRW 66,000 | Approx. 5,000 yen |
| Specification Page Fee (over 21 pages) | KRW 1,000 per page | KRW 1,000 per page | Approx. 100 yen/page |
| Request for Examination Fee | KRW 143,000 + additional fee per claim | Same as above | Approx. 14,300 yen and up |
| Claim surcharge (per claim) | KRW 44,000 | KRW 44,000 | Approx. 4,400 yen |
| Registration fee (for years 1–3) | KRW 45,000 + Claim Surcharge | Same as above | Approx. 4,500 yen– |
| Annuity (Years 4–6) | KRW 100,000/year + claim surcharge | Same as above | Approx. 10,000 yen/year |
| Annuity (7–9 years) | KRW 240,000/year + | Same as above | Approx. 24,000 yen/year |
| Pension (10–12 years) | KRW 480,000/year + | Same as above | Approx. 48,000 yen/year |
| Pension (13–25 years) | KRW 960,000/year + | Same as above | Approx. 96,000 yen/year |
SME and Individual Fee Reductions: Korean small and medium-sized enterprises (SMEs) and individual inventors are eligible for fee reductions of 30–70%. This may also apply to Korean subsidiaries of Japanese companies, making it worth considering as an intellectual property benefit of establishing a local legal entity.
| Provisions | Requirements | Practical Points |
|---|---|---|
| §29(1) | Novelty: No prior art, public use, or publication prior to the filing date | 12-month exception to loss of novelty (Section 30) |
| §29(2) | Inventive Step: Beyond the scope of what a person skilled in the art could readily invent | Criteria similar to Japan’s TSM test |
| §42 | Requirements for disclosure: clarity, enablement, and support | Similar to Article 36 of the Japanese Patent Act |
| §32 | Subjects Not Eligible for Patents: Methods of treating humans, etc. | Inventions relating to pharmaceutical products are acceptable |
| §33 | Right to Obtain a Patent: Generally Vests in the Inventor | Employer may succeed to rights in employee inventions (§39) |
| Case Law | Key Issues | Implications for Practice |
|---|---|---|
| Supreme Court 2016Hu526 | Claim Interpretation Method | Confirmed interpretation based on consideration of the entire specification, application history, and common technical knowledge. Importance of term definitions in the specification |
| Supreme Court 2014Hu1631 | Doctrine of Equivalents | Adoption of the five requirements equivalent to those in Japan. Guidelines for securing a scope of protection extending beyond the literal wording of the claims |
| Supreme Court 2018Da225, et al. | Inventive Step of Numerical Range Inventions | Simple numerical selection negates inventive step. Claims and data regarding specific effects (significance) are key |
| Supreme Court 2019Da270 | Damages for Patent Infringement | The 2019 amendment introduced triple damages (punitive damages). This serves as a powerful deterrent against willful infringement |
Key Points of the 2019 Amendment: South Korea introduced a system of triple damages for patent infringement (up to three times punitive damages), which is rare globally (Patent Act §128). If intentional infringement is established, a court may order damages of up to three times the actual damages, significantly enhancing bargaining power in licensing negotiations.
Remedies Available to Patent Holders
Patent infringement lawsuits are filed in district courts (particularly the Seoul Central District Court); following the 2016 amendment, appellate proceedings are now under the exclusive jurisdiction of the Intellectual Property Court. This has enhanced expertise and improved the predictability of judgments.
The most distinctive feature of the Korean patent system is its three-tiered system: “IPTAB (Intellectual Property Trial and Appeal Board) → Patent Court → Supreme Court.” While Japan has a two-tier system consisting of Japan Patent Office trials followed by the Intellectual Property High Court, the Korean system differs in that it includes an administrative trial body, the IPTAB, in the middle.
| Types of Proceedings | Eligible Applicants | Timeframe |
|---|---|---|
| Invalidity Trial (§133) | Interested parties | At any time |
| Proceedings for Determination of the Scope of Rights (§135) | Interested parties | At any time |
| Trial on Appeal Against a Decision of Rejection (§132-3) | Applicant | Within 30 days of service of the decision |
| Correction Trial (§136) | Patentee | At any time |
The term of a Korean patent is 20 years from the filing date. Annuity fees must be paid annually starting from the fourth year; failure to pay within six months of the due date results in revocation, although a reinstatement system (§81-3) exists for cases of force majeure or similar circumstances.
Extension System for Pharmaceuticals and Pesticides
| Item | Japan | South Korea |
|---|---|---|
| First-to-file system | First-to-File System | First-to-file system (identical) |
| Exceptions to the loss of novelty | 12 months | 12 months (identical) |
| Deadline for Requesting Examination | 3 years | 3 years (same) |
| Publication date | 18 months | 18 months (same) |
| Opposition procedure | Available (within 6 months of registration) | Abolished in 2017 → Replaced by invalidity proceedings |
| Judicial Structure | Japan Patent Office Trial and Appeal Board → Intellectual Property High Court → Supreme Court | IPTAB → Patent Court → Supreme Court (three-tier system) |
| Punitive Damages | None | Available (up to three times) |
| Language of Application | Japanese | Korean (English provisional applications are also acceptable; translation to follow) |
| PCT National Phase Entry Deadline | 30 months | 31 months (with a 1-month buffer) |
The Korean patent system is similar to Japanese patent law in many respects, making it a neighboring market where Japanese companies can easily formulate strategies. On the other hand, it also has unique elements such as a three-tier court system (IPTAB → Patent Court → Supreme Court), triple punitive damages, and a practice centered on invalidation trials following the abolition of opposition proceedings.The key to success lies in a strategic approach that balances both offensive and defensive measures, centered on claiming priority from a Japanese parent application, PCT national phase entry (within 31 months), and close collaboration with Korean patent attorneys. Please also see our PCT international patent application and patent application services.
EVORIX Intellectual Property Law Firm provides comprehensive support for patent applications and enforcement in major Asian countries, including South Korea. From designing IP portfolios spanning Japan and South Korea to responding to KIPO rejections, IPTAB trials, and Patent Court litigation, our patent attorneys—with extensive practical experience and close collaboration with local agents—are here to assist you.
*This article is intended to provide general information based on the Korean Patent Act (특허법), official KIPO materials, Supreme Court and Patent Court precedents, publicly available JETRO and WIPO documents, and explanations from Korean law firms. For specific assessments of individual cases, we recommend consulting with experts, including local patent attorneys.
AUTHOR / Author
Takefumi Sugiura
Managing Patent Attorney, EVORIX Intellectual Property Firm
Assists clients across a wide range of industries—including IT, manufacturing, startups, fashion, and healthcare—from patent, trademark, design, and copyright applications through to trials and infringement litigation. Also well-versed in intellectual property strategies for cutting-edge fields such as AI, IoT, Web3, and FinTech. Member of multiple organizations, including the Japan Patent Attorneys Association, the Asian Patent Attorneys Association (APAA), and the Japan Trademark Association (JTA).